Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB2 | P05107 | 1/20 | 0.42 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.42 |
| ▸ | ITGAL | P20701 | 1/20 | 0.42 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.42 |
| ▸ | BAD | Q92934 | 1/20 | 0.42 |
| ▸ | MAOA | P21397 | 1/20 | 0.41 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
| ▸ | SLC9A1 | P19634 | 2/20 | 0.40 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.40 |
| ▸ | MTNR1B | P49286 | 6/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | SLC9A5 | Q14940 | 1/20 | 0.38 |
| ▸ | SLC9A2 | Q9UBY0 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | CRHBP | P24387 | 2/20 | 0.38 |
| ▸ | CRHR2 | Q13324 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | AKT1 | P31749 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30054966 | 1.00 | ITGB2 (0.42) | ITGB2ICAM1ITGALBCL2L1BAD | |
| Formaldehyde SCHEMBL10956682 | 0.94 | MAOA (0.41) | ITGB2ICAM1ITGALBCL2L1BAD | |
| SCHEMBL5673196 | 0.88 | BCL2L1 (0.48) | ITGB2ICAM1ITGALBCL2L1BAD | |
| SCHEMBL31598947 | 0.88 | BCL2L1 (0.48) | ITGB2ICAM1ITGALBCL2L1BAD | |
| SCHEMBL3131795 | 0.79 | BCL2L1 (0.39) | BCL2L1BADMAOAMAOBPTGS2 | |
| SCHEMBL2938129 | 0.76 | MAOA (0.38) | MAOAMAOBSLC9A1MTNR1BMEN1 | |
| SCHEMBL19667519 | 0.75 | PNMT (0.41) | ITGB2ICAM1ITGALBCL2L1BAD | |
| SCHEMBL945134 | 0.74 | ITGB2 (0.42) | ITGB2ICAM1ITGALSLC9A1MTNR1B | |
| SCHEMBL2830923 | 0.74 | ITGB2 (0.42) | ITGB2ICAM1ITGALSLC9A1MTNR1B | |
| SCHEMBL8081108 | 0.74 | MAP3K14 (0.47) | ITGB2ICAM1ITGALMAOAMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 640 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4347571-B1 | TRIAZINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CANCER. | HOFFMANN LA ROCHE (CH) | 2026-04-22 | — | — | EP | claimed |
| US-20260092029-A1 | LIGAND-ENABLED SCALABLE C-H HYDROXYLATION OF BENZOIC AND PHENYLACETIC ACIDS AT ROOM TEMPERATURE | SCRIPPS RESEARCH INST (US) | 2026-04-02 | — | — | US | claimed |
| EP-4642784-A1 | HETEROCYCLIC AND HETEROARYL COMPOUNDS AS INHIBITORS OF NLRP3 | PTC Therapeutics, Inc. (US) | 2025-11-05 | — | — | EP | claimed |
| EP-4630420-A1 | INHIBITORS OF NLRP3 | F. Hoffmann-La Roche AG (CH) | 2025-10-15 | — | — | EP | claimed |
| EP-4584236-A1 | LIGAND-ENABLED SCALABLE C-H HYDROXYLATION OF BENZOIC AND PHENYLACETIC ACIDS AT ROOM TEMPERATURE | The Scripps Research Institute (US) | 2025-07-16 | — | — | EP | claimed |
| WO-2024145623-A1 | HETEROCYCLIC AND HETEROARYL COMPOUNDS AS INHIBITORS OF NLRP3 | PTC THERAPEUTICS, INC. (US) | 2024-07-04 | — | — | WO | claimed |
| WO-2024121184-A1 | INHIBITORS OF NLRP3 | F. HOFFMANN-LA ROCHE AG (CH) | 2024-06-13 | — | — | WO | claimed |
| WO-2024054881-A1 | LIGAND-ENABLED SCALABLE C-H HYDROXYLATION OF BENZOIC AND PHENYLACETIC ACIDS AT ROOM TEMPERATURE | THE SCRIPPS RESEARCH INSTITUTE (US) | 2024-03-14 | — | — | WO | claimed |
| EP-1323410-B1 | Sunscreen emulsion composition and method of use | AVON PROD INC (US) | 2006-09-13 | — | — | EP | claimed |
| EP-1323410-A2 | Sunscreen emulsion composition and method of use | AVON PRODUCTS, INC. (US) | 2003-07-02 | — | — | EP | claimed |
| US-6517816-B1 | Inner discontinuous phase and an outer continuous phase | AVON PRODUCTS, INC. | 2003-02-11 | — | — | US | claimed |
| EP-0252835-B1 | PROCESS FOR QUICK ELIMINATION OF HYDROGEN SULPHIDE CONTAINED IN LIQUID SULPHUR, AND CATALYTIC SYSTEM TO CARRY IT OUT | SOCIETE NATIONALE ELF AQUITAINE (PRODUCTION) (FR) | 1990-11-07 | — | — | EP | claimed |
| US-20260125381-A1 | NOVEL Kv3 CHANNEL MODULATORS | MERCK SHARP & DOHME LLC (US) | 2026-05-07 | — | — | US | disclosed |
| EP-4347571-B1 | TRIAZINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CANCER. | HOFFMANN LA ROCHE (CH) | 2026-04-22 | — | — | EP | disclosed |
| US-20260092029-A1 | LIGAND-ENABLED SCALABLE C-H HYDROXYLATION OF BENZOIC AND PHENYLACETIC ACIDS AT ROOM TEMPERATURE | SCRIPPS RESEARCH INST (US) | 2026-04-02 | — | — | US | disclosed |
| WO-2026046981-A1 | SOLID FORMS OF 5-[3-[[(3R)-1-ETHYL-3-PIPERIDYL]AMINO]-5-METHYL-1,2,4-TRIAZIN-6-YL]-2,3- DIHYDROBENZOFURAN-4-OL | F. HOFFMANN-LA ROCHE AG (CH) | 2026-03-05 | — | — | WO | disclosed |
| US-4494979-A | HERBICIDES;PLANT GROWTH REGULATORS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1985-01-22 | — | — | US | disclosed |
| US-4488896-A | Methods and compositions for the selective control of undesirable weed species in the presence of wet-land crops | AMERICAN CYANAMID COMPANY (US) | 1984-12-18 | — | — | US | disclosed |
| EP-0071441-A2 | Benzofuran sulfamates | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1983-02-09 | — | — | EP | disclosed |
| US-4289640-A | IMPROVED FOAMING AND DEGREASING PROPERTIES | COLGATE-PALMOLIVE COMPANY (US) | 1981-09-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260092029-A1 | LIGAND-ENABLED SCALABLE C-H HYDROXYLATION OF BENZOIC AND PHENYLACETIC ACIDS AT ROOM TEMPERATURE | CYP2B6, CYP2A6, CYP1A1 | ITGB2 3203/4885ICAM1 2138/4885ITGAL 3047/4885 |
| US-20260125381-A1 | NOVEL Kv3 CHANNEL MODULATORS | KCNN3, KCNA3, KCNQ3 | ITGB2 2343/4885ICAM1 1527/4885ITGAL 1774/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.